Van Der Maas P J, Van Delden J J, Pijnenborg L, Looman C W
Department of Public Health and Social Medicine, Erasmus University, Rotterdam, Netherlands.
Lancet. 1991 Sep 14;338(8768):669-74. doi: 10.1016/0140-6736(91)91241-l.
This article presents the first results of the Dutch nationwide study on euthanasia and other medical decisions concerning the end of life (MDEL). The study was done at the request of the Dutch government in preparation for a discussion about legislation on euthanasia. Three studies were undertaken: detailed interviews with 405 physicians, the mailing of questionnaires to the physicians of a sample of 7000 deceased persons, and the collecting of information about 2250 deaths by a prospective survey among the respondents to the interviews. The alleviation of pain and symptoms with such high dosages of opioids that the patient's life might be shortened was the most important MDEL in 17.5% of all deaths. In another 17.5% a non-treatment decision was the most important MDEL. Euthanasia by administering lethal drugs at the patient's request seems to have been done in 1.8% of all deaths. Since MDEL were taken in 38% of all deaths (and in 54% of all non-acute deaths) we conclude that these decisions are common medical practice and should get more attention in research, teaching, and public debate.
本文介绍了荷兰全国范围内关于安乐死及其他有关生命末期医疗决策(MDEL)研究的首批结果。该研究应荷兰政府要求开展,为安乐死立法讨论做准备。研究开展了三项工作:对405名医生进行详细访谈;向7000名逝者样本的医生邮寄调查问卷;通过对访谈受访者进行前瞻性调查收集2250例死亡的相关信息。在所有死亡案例中,17.5%的案例中使用高剂量阿片类药物缓解疼痛和症状从而可能缩短患者生命是最重要的MDEL。另有17.5%的案例中,不进行治疗的决策是最重要的MDEL。应患者要求给予致命药物实施安乐死的情况似乎占所有死亡案例的1.8%。由于38%的死亡案例(以及54%的非急性死亡案例)都做出了MDEL,我们得出结论,这些决策是常见的医疗行为,在研究、教学和公众辩论中应得到更多关注。